Jan Siehl
Impact in
- Ophthalmology top 5%
- Ocular Oncology and Treatments
- Oncology top 10%
- Viral-associated cancers and disorders
- Cutaneous Melanoma Detection and Management
Papers in
-
- Multiple Myeloma Research and Treatments 3
- Acute Myeloid Leukemia Research 2
- Platelet Disorders and Treatments 2
- Oncology 7
- Viral-associated cancers and disorders 7
- Co-authors
- Eckhard Thiel (10 shared papers)Ulrich Keilholz (13 shared papers)E. Thiel (4 shared papers)Alexander H. Schmittel (7 shared papers)Agnieszka Korfel (1 shared paper)Beate Gleissner (1 shared paper)Richard Reinhardt (1 shared paper)Marcus Hentrich (6 shared papers)
In The Last Decade
Jan Siehl
23 papers receiving 581 citations
Peers
Comparison fields: 5 of 43
- Ophthalmology 102
- Oncology 191
- Hematology 64
- Pathology and Forensic Medicine 72
- Neurology 51
Countries citing papers authored by Jan Siehl
This map shows the geographic impact of Jan Siehl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Siehl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Siehl more than expected).
Fields of papers citing papers by Jan Siehl
This network shows the impact of papers produced by Jan Siehl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Siehl. The network helps show where Jan Siehl may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Siehl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 92 | |
| 2 | 2002 | 79 | |
| 3 | 2006 | 73 | |
| 4 | 2007 | 38 | |
| 5 | 2004 | 36 | |
| 6 | 2005 | 34 | |
| 7 | 1999 | 32 | |
| 8 | 2018 | 28 | |
| 9 | 2003 | 27 | |
| 10 | 2011 | 26 | |
| 11 | 2002 | 24 | |
| 12 | 2009 | 24 | |
| 13 | 2005 | 23 | |
| 14 | 2014 | 21 | |
| 15 | 2004 | 16 | |
| 16 | 2017 | 13 | |
| 17 | 2000 | 7 | |
| 18 | 2013 | 6 | |
| 19 | 2001 | 5 | |
| 20 | Phase II trial of carboplatin, paclitaxel plus vinorelbine in non-small cell lung cancer patients. | 2005 | 4 |
About Jan Siehl
Jan Siehl is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Ophthalmology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 611 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (7 papers), Lymphoma Diagnosis and Treatment (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Ocular Oncology and Treatments (3 papers), Multiple Myeloma Research and Treatments (3 papers), Acute Myeloid Leukemia Research (2 papers), Platelet Disorders and Treatments (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Ophthalmology (102 citations), Oncology (191 citations), Hematology (64 citations), Pathology and Forensic Medicine (72 citations) and Neurology (51 citations). Jan Siehl has collaborated with scholars based in Germany, Austria and Poland. Frequent co-authors include Eckhard Thiel, Ulrich Keilholz, E. Thiel, Alexander H. Schmittel, Agnieszka Korfel, Beate Gleissner, Richard Reinhardt, Marcus Hentrich, Hans Dietrich Menssen and Christoph Wyen. Their work appears in journals such as Annals of Hematology, Annals of Oncology, European Journal of Cancer, HemaSphere and Recent results in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.